Description

Compound 7P Powder

Compound 7P
CAS Number	1890208-58-8
Molar Mass	441.5 g/mol
Chemical Formula	C22H23N3O5S
IUPAC Name	Compound 7P; CHEMBL3824120

Introduction

Compound 7P Powder is an advanced research product engineered for scientific investigations in the fields of neurobiology and oncology. This powdered compound, known as Compound 7P, is renowned for its potential in various research applications. It is of utmost importance to underscore that this product is exclusively intended for research purposes and should not be considered for human consumption.

Key Characteristics

Compound 7P Powder is characterized by its exceptional purity and ease of handling. This finely milled powder is synthesized and quality-tested to meet the highest standards, ensuring its reliability in diverse research applications.

Research Applications

Researchers and scientists can employ Compound 7P Powder in a range of research areas, including studies on neurite outgrowth activity and cancer. The versatile powdered form offers precision in dosing and application, making it a valuable tool for the comprehensive exploration of Compound 7P’s potential in these domains.

Research Benefits

Compound 7P on in vitro Neurite Outgrowth Activity

Research has indicated that Compound 7P may have a positive effect on in vitro neurite outgrowth activity. Neurite outgrowth is essential for neural development and regeneration. This property of Compound 7P can be explored to enhance our understanding of neurobiology and potential applications in neurodegenerative research.

Compound 7P on Cancer

Initial studies suggest that Compound 7P may exhibit potential in cancer research, with implications for inhibiting the growth of certain cancer cell lines. Researchers can investigate its impact on cancer cell behavior and molecular mechanisms, shedding light on potential therapeutic avenues.

Summary

Compound 7P Powder is a research product meticulously designed for scientific investigations in neurobiology and oncology. With its high purity and versatile powdered form, it offers an optimal choice for a wide range of research applications. Researchers can explore the potential benefits of Compound 7P on neurite outgrowth activity and its potential implications in cancer research, with the support of existing scientific literature.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Ku JM, Park K, Lee JH, Cho KJ, Nam YJ, Jeong DY, Kim YH, Kwon S, Park JY, Yang J, Nam TG, Yoon SH, Ahn S, Choi Y. Discovery, Optimization, and Biological Evaluation of Sulfonamidoacetamides as an Inducer of Axon Regeneration. J Med Chem. 2016 May 26;59(10):4676-87. doi: 10.1021/acs.jmedchem.6b00015. Epub 2016 Apr 22. PMID: 27007292. [Read More]
2. Wang X, Yi Y, Lv Q, Zhang J, Wu K, Wu W, Zhang W. Novel 1,3,5-triazine derivatives exert potent anti-cervical cancer effects by modulating Bax, Bcl2 and Caspases expression. Chem Biol Drug Des. 2018 Mar;91(3):728-734. doi: 10.1111/cbdd.13133. Epub 2017 Nov 15. PMID: 29068538.[Read More]